DNP 825 Topic 4 screening program analysis example

Population Management Grand Canyon University Free custom sample in 24 to 48h

This DNP 825 Topic 4 sample paper works the arithmetic of screening 6,800 older adults with hypertension for atrial fibrillation with a 30-second single-lead ECG at blood pressure visits. It was prepared for GCU DNP 825, Population Management, catalog code DNP-825, part of Grand Canyon University's DNP. At 1.2 percent prevalence, 81 of 82 cases are found and 578 people are falsely alarmed, a positive predictive value of 12.3 percent. Each false positive is followed through a confirmatory 12-lead ECG and its staff time. True positives are followed into anticoagulation capacity. The number needed to screen is about 85, and the 2022 USPSTF statement shapes a conditional pilot.

CourseDNP 825 Population Management
TopicTopic 4
Paper typeScreening program arithmetic
LengthAbout 1,080 words, 3 pages
FormatAPA 7 student paper
SchoolGrand Canyon University (GCU)
ProgramDNP
UpdatedOctober 2026

Free sample paper for DNP 825 Topic 4

1

Eighty-One Found, 578 Alarmed: The Arithmetic of Screening Older Adults With Hypertension for Atrial Fibrillation With a Single-Lead ECG at Blood Pressure Visits

[Author Name]

College of Nursing and Health Care Professions, Grand Canyon University

DNP-825: Population Management

Topic 4 Assignment

[Instructor Name]

August 23, 2027

The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.

What this page is doingThe title leads with true and false positives, which is the arithmetic most screening proposals leave out. The health system, its prevalence and capacity figures are composites; test accuracy and trial results are from the cited studies.
2

Eighty-One Found, 578 Alarmed: The Arithmetic of Screening Older Adults With Hypertension for Atrial Fibrillation With a Single-Lead ECG at Blood Pressure Visits

The Condition, the Test and the Population

A proposal has reached the population health committee: while patients are already at the medical assistant blood pressure visits described in Topic 3, record a 30-second single-lead ECG with a handheld device and screen for atrial fibrillation. The population is the 6,800 attributed adults aged 65 or older who meet the system's hypertension definition and have no recorded atrial fibrillation. Undetected atrial fibrillation matters because it raises stroke risk, and anticoagulation lowers that risk once the rhythm is known.

Everything in this analysis depends on the prevalence of undiagnosed atrial fibrillation in this population, so the figure is taken from local data rather than borrowed. In 2026, 4,000 people in this group had a 12-lead ECG recorded for another reason, such as a preoperative assessment, and 48 of them, 1.2 percent, had atrial fibrillation not previously recorded. That is close to the published figure of 1.4 percent for previously unknown atrial fibrillation found by single time-point screening in adults 65 and older (Lowres et al., 2013), which gives some confidence that the local estimate is reasonable. The device's automated algorithm is taken to have the accuracy reported in a pharmacy screening study of 1,000 adults 65 and older: 98.5 percent sensitivity and 91.4 percent specificity (Lowres et al., 2014).

The Arithmetic at 1.2 Percent Prevalence

Table 1

Expected Results of One Round of Single-Lead ECG Screening in 6,800 Adults

Atrial fibrillation presentAtrial fibrillation absentTotal
Screen positive81 (true positives)578 (false positives)659
Screen negative1 (false negative)6,140 (true negatives)6,141
Total826,7186,800

Screening all 6,800 once produces the results in Table 1. Of 6,800 people, 82 have undiagnosed atrial fibrillation and 6,718 do not. With 98.5 percent sensitivity, the algorithm flags 81 of the 82 and misses 1. With 91.4 percent specificity, it correctly clears 6,140 of the 6,718 without atrial fibrillation and falsely flags 578.

What the Positive Result Means

The predictive value of a positive result is 81 divided by 659, or 12.3 percent. Nearly nine of every ten people told their screening result was abnormal do not have atrial fibrillation. The test is accurate; the condition is uncommon, and at low prevalence even a small false-positive rate produces far more false positives than true ones. The predictive value of a negative result is 6,140 divided by 6,141, which is reassuring but adds little, since almost everyone in this group would have been negative anyway.

Following the False Positives

Each of the 578 false positives generates work and worry. Each needs a confirmatory 12-lead ECG, which here means a scheduled visit rather than a same-day test at most clinics, about 30 minutes of staff time and a clinician review. That is roughly 290 hours of visit time in the screening year, taken from the same schedule that Topic 3 found to be 19 days out. Some will have ambiguous 12-lead results and need ambulatory monitoring. Every one of them spends days or weeks believing they may have a heart rhythm problem. This burden can be reduced before screening starts. In the pharmacy study, tracings were over-read by a cardiologist, and the automated algorithm's specificity figure describes the algorithm alone (Lowres et al., 2014). Routing every automated positive to a clinician for tracing review before contacting the patient would remove many false positives at the cost of a few minutes per tracing.

Following the True Positives

Finding 81 people with atrial fibrillation is useful only if the treatment pathway can absorb them. All 81 are 65 or older with hypertension, so almost all will have a stroke risk score high enough to warrant a discussion of anticoagulation. Each needs a clinician visit for that decision, most will need an echocardiogram, and many will be referred to cardiology. The anticoagulation clinic currently runs at about 90 percent of capacity with 40 new patients a month; 81 new patients spread across a screening year adds about 7 a month, which it can absorb. Cardiology is the constraint: the current wait for a new outpatient appointment is 11 weeks. Adding 81 referrals without a fast-track agreement would push that wait out further for everyone, including patients with symptoms.

The committee should also know what the trial evidence shows about outcomes. In a trial of 6,004 adults aged 70 to 90 with stroke risk factors, 91 percent of whom had hypertension, continuous monitoring with implantable loop recorders tripled atrial fibrillation detection and more than doubled anticoagulation starts, but the reduction in stroke and systemic embolism did not reach significance (hazard ratio 0.80, p = 0.11), and major bleeding was somewhat higher (Svendsen et al., 2021). The US Preventive Services Task Force (2022) gave screening for atrial fibrillation in symptom-free adults 50 and older an I statement: the evidence did not allow it to say whether benefits outweigh harms. Finding more atrial fibrillation does not by itself establish that screening prevents strokes.

Number Needed to Screen

The number needed to screen to find one new case is 1 divided by the product of prevalence and sensitivity: 1 divided by (0.012 times 0.985), or about 85. In resource terms, finding each new case of atrial fibrillation costs about 85 ECG recordings, 7 confirmatory 12-lead ECG visits for people who turn out not to have it, and the anxiety of those 7 people. The number needed to screen to prevent one stroke cannot be calculated with confidence from current evidence, because the trials have not shown a significant stroke reduction from screening, and I will not present a figure the evidence does not support.

What this page is doingEvery figure is worked from the local prevalence stated at the start, and the true positives are followed into a pathway whose capacity is checked. The recommendation then follows from the arithmetic rather than from the test's accuracy alone.
3

A Conditional Recommendation

I recommend that the system not begin population-wide screening now, and that it run a limited pilot at two clinics if two conditions are arranged first. The first is clinician over-read of every automated positive before the patient is contacted, with a target turnaround of two working days, so that the false positives reaching patients fall well below 578. The second is a cardiology fast-track agreement for newly identified atrial fibrillation, with a named cardiologist and a maximum wait of three weeks, so that true positives do not lengthen the wait for symptomatic patients. The pilot would report positive predictive value after over-read, confirmatory visits generated, time from positive screen to anticoagulation decision and the share of new cases started on anticoagulation. Whether screening becomes population-wide should depend on those local numbers and on any new trial evidence about stroke outcomes.

References

Lowres, N., Neubeck, L., Redfern, J., & Freedman, S. B. (2013). Screening to identify unknown atrial fibrillation: A systematic review. Thrombosis and Haemostasis, 110(2), 213-222. https://doi.org/10.1160/TH13-02-0165

Lowres, N., Neubeck, L., Salkeld, G., Krass, I., McLachlan, A. J., Redfern, J., Bennett, A. A., Briffa, T., Bauman, A., Martinez, C., Wallenhorst, C., Lau, J. K., Brieger, D. B., Sy, R. W., & Freedman, S. B. (2014). Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies: The SEARCH-AF study. Thrombosis and Haemostasis, 111(6), 1167-1176. https://doi.org/10.1160/TH14-03-0231

Svendsen, J. H., Diederichsen, S. Z., Højberg, S., Krieger, D. W., Graff, C., Kronborg, C., Olesen, M. S., Nielsen, J. B., Holst, A. G., Brandes, A., Haugan, K. J., & Køber, L. (2021). Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): A randomised controlled trial. The Lancet, 398(10310), 1507-1516. https://doi.org/10.1016/S0140-6736(21)01698-6

US Preventive Services Task Force. (2022). Screening for atrial fibrillation: US Preventive Services Task Force recommendation statement. JAMA, 327(4), 360-367. https://doi.org/10.1001/jama.2021.23732

DNP 825 Topic 4 instructions, in plain terms

Topic 4 in DNP-825 asks students to evaluate a screening program for a population. Strong evaluations state the condition, the test with its sensitivity and specificity and the population with its prevalence, then work the results for the whole population in a two-by-two table. Students should calculate and interpret predictive values, follow false positives through the work and worry they create and check whether the treatment pathway can absorb the true positives. The number needed to screen should be translated into resources, and the recommendation should reflect current guidance such as the US Preventive Services Task Force statement, which may be conditional. A two-by-two table for the whole population is the clearest way to show the arithmetic.

Inside the DNP 825 Topic 4 example

The finished example does the arithmetic that most proposals skip. A test with strong sensitivity and specificity is applied to a population where the condition is uncommon, and the predictive value of a positive result turns out to be modest, which means most positives are false. The paper counts them, because each one generates a confirmatory test, an interval of anxiety and a cost. Number needed to screen is calculated and stated plainly. The example also asks what happens to true positives, since finding a condition is only useful if the treatment pathway has capacity, and it checks whether it does. The recommendation that follows is conditional on two things being arranged first.

Where the marks sit in the DNP 825 Topic 4 rubric

Faculty reward screening judged by its arithmetic. An Excellent paper tables results for 6,800 adults at 1.2 percent prevalence, finding 81 cases and 578 false positives. Credit goes to a positive predictive value of 12.3 percent explained in plain terms, with test accuracy from Lowres and colleagues. The rubric values following false positives into confirmatory ECGs and true positives into anticoagulation discussions, with Svendsen and colleagues' LOOP trial as caution. Strong papers turn a number needed to screen of about 85 into staff time. Top marks go to a conditional two-clinic pilot.

DNP 825 Topic 4 help before you submit

The failure this topic reliably exposes is a proposal quoting sensitivity and specificity without ever calculating predictive value at the local prevalence. A second weakness is treating false positives as a footnote, when in an uncommon condition they outnumber true cases and consume most of the program's downstream cost. Marks also go for ignoring treatment capacity, since a screening program that finds cases nobody can treat has produced diagnosis without benefit. Proposals with no number needed to screen give a budget holder nothing to work with. Recommendations offered unconditionally assume arrangements that may not exist. Prevalence figures quoted with no source undermine every calculation resting on them. Programs proposed with no interval between screens leave the schedule and the cost open ended.

Get a DNP-825 Topic 4 example written to your instructions

Send the DNP-825 Topic 4 instructions and the rubric your classroom posts, with the condition and test your section assigned. We write a custom example to those criteria, worked at local prevalence with false positives followed to their cost, treatment capacity checked and a conditional recommendation, in 24 to 48 hours. The first is free.

More DNP 825 papers and DNP samples

DNP 825 Topic 4 questions, answered

Why does prevalence change the answer?

Because predictive value depends on it. A test with ninety five percent specificity applied to a population where one percent has the condition will produce far more false positives than true ones, however good it sounds. The test has not changed; the population has. Doing the arithmetic at your own prevalence is the single most important calculation in the paper.

What is the real cost of a false positive?

A confirmatory test, an interval of anxiety, occasionally an invasive procedure, and a person who now distrusts the program. Multiplied across a screening population, that becomes the dominant cost in an uncommon condition. Counting them explicitly is what separates a proposal from an enthusiasm, and it frequently changes the recommendation.

Why check treatment capacity?

Because screening without a pathway produces diagnosis and nothing else. If finding two hundred additional cases means a clinic already booked eleven weeks out has to absorb them, the program will either fail or displace existing patients. Establishing capacity before recommending screening is what separates a plan from an enthusiasm.

Where can I find a free DNP 825 Topic 4 sample paper?

The screening analysis for DNP 825 Topic 4 covers the condition, test and population, the arithmetic at 1.2 percent, what a positive result means, false positives, true positives, the number needed to screen and a conditional recommendation. Your own DNP 825 Topic 4 prompt gets a free analysis.

Why does prevalence matter so much in DNP 825 Topic 4?

Predictive value depends on it. At 1.2 percent prevalence, even a test with high specificity produces more false positives than true ones, so most people told their result is abnormal are well.